Croda reported 6.6% organic sales growth in the third quarter, driven by consumer care up 10.8%, and reaffirmed its 2026 outlook of 3%-6% organic growth. Shares rose about 3.5% to a 52-week high on Nov. 5.
Croda aims to consistently improve its portfolio mix toward the higher end of the quality spectrum in all the market niches in which it plays, which should bode well for a further reduction in cyclicality and margin improvement.
Bears
Croda was late to develop its business in emerging markets compared with peers, which may reduce its competitiveness in these higher-growth areas.
Croda is a British specialty chemicals company with 60% of sales outside Europe. Croda operates through three segments: consumer care, life sciences, and industrial specialties. Consumer care produces specialty and active ingredients for cosmetics and skincare/haircare and also flavors and fragrances. The life sciences business manufactures products for healthcare and agrichemicals. The company sold the majority of its industrial businesses to Cargill in 2022, retaining only a subsegment of the business (industrial specialties segment) that supports the other two segments and sells their byproducts.